» Articles » PMID: 21940501

Defining the Cellular Precursors to Human Breast Cancer

Abstract

Human breast cancers are broadly classified based on their gene-expression profiles into luminal- and basal-type tumors. These two major tumor subtypes express markers corresponding to the major differentiation states of epithelial cells in the breast: luminal (EpCAM(+)) and basal/myoepithelial (CD10(+)). However, there are also rare types of breast cancers, such as metaplastic carcinomas, where tumor cells exhibit features of alternate cell types that no longer resemble breast epithelium. Until now, it has been difficult to identify the cell type(s) in the human breast that gives rise to these various forms of breast cancer. Here we report that transformation of EpCAM(+) epithelial cells results in the formation of common forms of human breast cancer, including estrogen receptor-positive and estrogen receptor-negative tumors with luminal and basal-like characteristics, respectively, whereas transformation of CD10(+) cells results in the development of rare metaplastic tumors reminiscent of the claudin-low subtype. We also demonstrate the existence of CD10(+) breast cells with metaplastic traits that can give rise to skin and epidermal tissues. Furthermore, we show that the development of metaplastic breast cancer is attributable, in part, to the transformation of these metaplastic breast epithelial cells. These findings identify normal cellular precursors to human breast cancers and reveal the existence of a population of cells with epidermal progenitor activity within adult human breast tissues.

Citing Articles

Defining the regulatory logic of breast cancer using single-cell epigenetic and transcriptome profiling.

Regner M, Garcia-Recio S, Thennavan A, Wisniewska K, Mendez-Giraldez R, Felsheim B Cell Genom. 2025; 5(2):100765.

PMID: 39914387 PMC: 11872555. DOI: 10.1016/j.xgen.2025.100765.


A hybrid epithelial-mesenchymal transition program enables basal epithelial cells to bypass stress-induced stasis and contributes to a metaplastic breast cancer progenitor state.

Caruso J, Chen-Tanyolac C, Tlsty T Breast Cancer Res. 2024; 26(1):184.

PMID: 39696672 PMC: 11657373. DOI: 10.1186/s13058-024-01920-8.


Oncogene activated human breast luminal progenitors contribute basally located myoepithelial cells.

Kohler K, Kim J, Villadsen R, Ronnov-Jessen L, Petersen O Breast Cancer Res. 2024; 26(1):183.

PMID: 39695857 PMC: 11656586. DOI: 10.1186/s13058-024-01939-x.


Defining the transcriptional lineages of breast cancer subtypes.

Nat Cancer. 2024; 5(11):1605-1606.

PMID: 39478118 DOI: 10.1038/s43018-024-00774-5.


Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages.

Iglesia M, Jayasinghe R, Chen S, Terekhanova N, Herndon J, Storrs E Nat Cancer. 2024; 5(11):1713-1736.

PMID: 39478117 PMC: 11584403. DOI: 10.1038/s43018-024-00773-6.


References
1.
Elenbaas B, Spirio L, Koerner F, Fleming M, Zimonjic D, Donaher J . Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 2001; 15(1):50-65. PMC: 312602. DOI: 10.1101/gad.828901. View

2.
Villadsen R, Fridriksdottir A, Ronnov-Jessen L, Gudjonsson T, Rank F, LaBarge M . Evidence for a stem cell hierarchy in the adult human breast. J Cell Biol. 2007; 177(1):87-101. PMC: 2064114. DOI: 10.1083/jcb.200611114. View

3.
Eirew P, Stingl J, Raouf A, Turashvili G, Aparicio S, Emerman J . A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability. Nat Med. 2008; 14(12):1384-9. DOI: 10.1038/nm.1791. View

4.
Livasy C, Karaca G, Nanda R, Tretiakova M, Olopade O, Moore D . Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol. 2005; 19(2):264-71. DOI: 10.1038/modpathol.3800528. View

5.
Polyak K . Breast cancer: origins and evolution. J Clin Invest. 2007; 117(11):3155-63. PMC: 2045618. DOI: 10.1172/JCI33295. View